Aspergillus endophthalmitis: An unusual complication of disseminated infection in renal transplant patients

Journal of Infection

Volumn 47, Issue 4, 2003, Pages 336-343

  Schelenz, S ^a   Goldsmith, D J A ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Aspergillus; Endophthalmitis; Renal transplant

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; LIPOSOME; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; METICILLIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIFAMPICIN; STEROID; SULFADIAZINE; TACROLIMUS; TERBINAFINE; VANCOMYCIN; VORICONAZOLE;

ABDOMINAL PAIN; ADULT; ASPERGILLOSIS; ASPERGILLUS; BRAIN INFECTION; CASE REPORT; CEREBROSPINAL FLUID; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; DRUG BLOOD LEVEL; DRUG PENETRATION; ENDOPHTHALMITIS; EYE; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; MEDICAL DECISION MAKING; MEDLINE; MICROSCOPY; MORTALITY; NAUSEA; OPPORTUNISTIC INFECTION; OUTCOMES RESEARCH; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SHUNT INFECTION; TOXOPLASMOSIS; VITRECTOMY; VITREOUS BODY; VOMITING;

EID: 0142149144     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(03)00078-1     Document Type: Article

References (42)

1. Altiparmak MR, Apaydin S, Trablus S, Serdengecti K, Ataman R, Ozturk R, Erek E. Systemic fungal infections after renal transplantation. Scand J Infect Dis 2002;34(4):284-288.
2. Weiland D, Ferguson RM, Peterson PK, et al. Aspergillosis in 25 renal transplant patients: epidemiology, clinical presentation, diagnosis and management. Ann Surg 1983;198: 622-629.
3. Cornet M, Fleury L, Maslo C, Bernard J-F, Brücker G, et al. Epidemiology of invasive aspergillosis in France: a six-year multicenter survey in the Greater Paris area. J Hosp Infect 2002;51:288-296.
4. Lin S-J, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. CID 2001;32: 358-366.
5. Ingwer I, McLeish KR, Tight RR, et al. Aspergillus fumigatus epidural abscess in a renal transplant recipient. Arch Intern Med 1978;138:153-154.
6. Petersen M, Althaus C, Santen R, Gerharz CD. Endogenous Aspergillus endophthalmitis in AIDS. Klin Monatsbl Augenheilkd 1997;211:400-402.
7. Follows GA, Hutchinson C, Martin A, Carter C. Aspergillus fumigatus endophthalmitis in patient with acute myeloid leukaemia. Clin Lab Haem 1999;21:143-144.
8. Rao NA, Hidayat AA. Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Opthalmol 2001; 132:244-251.
9. Hunt KE, Glasgow BJ. Aspergillus endophthalmitis. An unrecognized endemic disease in orthotopic liver transplantation. Ophthalmology 1996;103(7):1061-1062.
10. Anteby I, Kramer M, Rahv GT, Benezra D. Necrotising choroiditis-retinitis as presenting symptom of disseminated aspergillosis after lung transplantation. Eur J Ophthalmol 1997;7:294-296.
11. Augsten R, Konigsdorffer E, Oehme A, Strobel J. Bilateral endogenous endophthalmitis. Klin Monatsbl Augenheilkd 1998;212(2):120-122.
12. Barr CC, Walsh A, Wainscott B, Finger R. Aspergillus endophthalmitis in intravenous-drug users-Kentucky. JAMA 1990;263:941.
13. Michelson JB, Freedman SD, Boyden DG. Aspergillus endophthalmitis in a drug abuser. Ann Ophthalmol 1982; 14:1051-1054.
14. Weishaar PD, Flynn HW, Murray TG, Davis JL, Barr CC, Gross JG, Mein CE, Mclean WC, Killian JH. Endogenous Aspergillus endophthalmitis: clinical features and treatment outcomes. Ophthalmology 1998;105:57-65.
15. Riddell J, McNeil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA. Endogenous Aspergillus endophthalmitis. Medicine 2002;81:311-320.
16. Burton JR, Zachery JB, Bessin R, Rathbun HK, Greenough WB, Sterioff S, Wright JR, Slavin RE, Williams GM. Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B. Ann Intern Med 1972;77:383-388.
17. Neidoff MA, Green WR. Endogenous Aspergillus endophthalmitis occurring after kidney transplant. Am J Ophthalmol 1975;79(3):502-509.
18. Weiss JN, Hutchins RK, Balogh K. Simultaneous Aspergillus endophthalmitis and cytomegalovirus retinitis after kidney transplantation. Retina 1988;8:193-198.
19. Sarmiento JM, Dockrell DH, Schwab TR, Munn SR, Paya CV. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant 2000;14:136-138.
20. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group, A lind, randomised clinical trial of mycophenolate mofetil for prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996;61:1029-1037.
21. US Renal Transplant Mycophenolate Mofetil Study Group, Mycophenolate Mofetil in cadaveric renal transplantation. Am J Kidney Dis 1999;34(2):296-303.
22. Singh N, Arnow PM, Bonham A, Dominguez E, Paterson DL, Pankey GA, Wegener MM, Yu VL. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997; 64(5):716-720.
23. Husni RN, Gorden SM, Longworth DL, Arroliga A, Stillwell PC, Avery RK, Maurer JR, Mehta A, Kirby T. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998;26:753-755.
24. Schaffner A, Schaffner T. Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanism and dependence on the state of activation. Rev Infect Dis 1987; 9:S620-S629.
25. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14: 436-441.
26. Levitz SM, Selsted ME, Ganz T, Lehrer RI, Diamond RD. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizophus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis 1986;154: 2544-2551.
27. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983;148(2):230-238.
28. Nenoff P, Kellermann S, Horn LC, Keiner S, Bootz F, Schneider S, Haustein UF. Case report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis. Mycoses 2001;44(9-10):407-414.
29. Kim DG, Hong SC, Kim HJ, Chi JG, Han MH, Choi KS, Han DH. Cerebral aspergillosis in immunologically competent patient. Surg Neurol 1993;40(4):326-331.
30. Tietz A-J, Martin H, Koch S. Incidence of endomycoses in autopsy material. Mycoses 2001;44:450-454.
31. Fortun J, Martin-Davila P, Alvarez ME, Sanchez-Sousa A, Quereda C, Navas E, Barcena R, Vicente E, Candelas A, Honrubia A, Nuno J, Pintado V, Moreno S. Aspergillus antigenemia sandwich-enzyme immunoassay test as serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001;71(1):145-149.
32. Viscoli C, Machetti M, Gazzola P, De Maria A, Paola D, Van Lint MT, Gualandi F, Truini M, Bacigalupo A. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Micro 2002;40(4):1296-1499.
33. Jaeger EEM, Carroll NM, Choudhury S, et al. Rapid identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin Microbiol 2000; 38:2902-2908.
34. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000;30:606-709.
35. Fisher JF, Taylor T, Clark J, Rao R. Penetration of amphotericin B into the human eye. J Infect Dis 1983;147: 164.
36. Green WR, Bennett JE, Goos RD. Ocular penetration of amphotericin B. Arch Ophthalmol 1965;73:769-775.
37. Savani SV, Perfect JR, Cobo M, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother 1987;31:6-10.
38. Zhou L, Glickman RD, Chen N, Sponsel WE, Graybill JR, Lam KW. Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr Analyt Technol Biomed Life Sci 2002;776(2):213-220.
39. Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, Douglas CM. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother 2002; 46(9):3001-3012.
40. Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol 2001;39(1):91-95.
41. Winston DJ, Busuttil RW. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 2002;74(5):688-695.
42. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001;71(7):910-913.